Correction to: Gr-MDSC-linked asset as a potential immune biomarker in pretreated NSCLC receiving nivolumab as second-line therapy.
Clin Transl Oncol
; 22(4): 621, 2020 04.
Article
em En
| MEDLINE
| ID: mdl-31432394
ABSTRACT
Acknowledgements section was missing.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
En
Revista:
Clin Transl Oncol
Ano de publicação:
2020
Tipo de documento:
Article
País de afiliação:
Itália